Expedited Pharmacometrics Regulatory Submissions Fact Sheet Expedited Pharmacometrics Regulatory Submissions Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…Certara2025 年 12 月 8 日
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings Announcement Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.Certara2025 年 12 月 3 日
Supporting KalVista’s NDA Submission for a Novel HAE Treatment Case Study Supporting KalVista’s NDA Submission for a Novel HAE Treatment To accelerate the first oral therapy for hereditary angioedema (HAE), KalVista Pharmaceuticals partnered with Certara…Danielle Pillsbury2025 年 11 月 12 日
Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation Publication Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…Certara2025 年 11 月 5 日
Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights On-Demand Webinar Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…Certara2025 年 11 月 3 日
Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Publication Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…Certara2025 年 10 月 31 日
AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success On-Demand Webinar AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…Certara2025 年 10 月 21 日